Additionally, in a study investigating the protein–protein interactions of TRIP13 in head and neck cancer, suggesting a potential role in promoting tumor drug resistance via the nonhomologous end-joining (NHEJ) signaling pathway. Here, TRIP13 is linked to head and neck cancer.